Votubia 2 mg Dispersible tablet

Licence status
Authorised: 15/11/2013
Active substances
Rad n bht
Dosage Form
Dispersible tablet
Licence number
EU/1/11/710/009-011
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE10 everolimus
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/11/2013